Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SNCA | P37840 | 6/20 | 0.58 |
| ▸ | NOX1 | Q9Y5S8 | 13/20 | 0.48 |
| ▸ | GAA | P10253 | 4/20 | 0.48 |
| ▸ | MAPT | P10636 | 4/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | BCHE | P06276 | 2/20 | 0.46 |
| ▸ | ACHE | P22303 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.45 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.45 |
| ▸ | MAOA | P21397 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30065446 | 1.00 | SNCA (0.58) | SNCANOX1GAAMAPTMAPK1 | |
| SCHEMBL28407357 | 0.92 | SNCA (0.47) | SNCANOX1GAAMAPTMAPK1 | |
| SCHEMBL2582828 | 0.92 | SNCA (0.66) | SNCANOX1GAAMAPTMAPK1 | |
| SCHEMBL29637682 | 0.92 | SNCA (0.66) | SNCANOX1GAAMAPTMAPK1 | |
| Bromide SCHEMBL30448580 | 0.90 | SNCA (0.64) | SNCANOX1GAAMAPTMAPK1 | |
| Bromide SCHEMBL20495634 | 0.90 | SNCA (0.64) | SNCANOX1GAAMAPTMAPK1 | |
| SCHEMBL28635096 | 0.88 | NOX1 (0.65) | SNCANOX1GAAMAPTMAPK1 | |
| SCHEMBL4706809 | 0.86 | SNCA (0.45) | SNCANOX1GAAMAPTMAPK1 | |
| SCHEMBL30769565 | 0.86 | NOX1 (0.65) | SNCANOX1GAAMAPTMAPK1 | |
| SCHEMBL239782 | 0.86 | NOX1 (0.65) | SNCANOX1GAAMAPTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115490854-B | Polyimide with low dielectric, high heat resistance and low water absorption and high performance, and preparation method and application thereof | 江西有泽新材料科技有限公司 | 2024-01-30 | — | — | CN | claimed |
| CN-115490854-A | Low-dielectric, high-heat-resistant and low-water-absorption high-performance polyimide, and preparation method and application thereof | 江西有泽新材料科技有限公司 | 2022-12-20 | — | — | CN | claimed |
| CN-115490854-B | Polyimide with low dielectric, high heat resistance and low water absorption and high performance, and preparation method and application thereof | 江西有泽新材料科技有限公司 | 2024-01-30 | — | — | CN | disclosed |
| CN-111087364-B | Antibacterial diamine prepared from medical intermediate and preparation method thereof | 广东高义包装科技股份有限公司 | 2023-03-31 | — | — | CN | disclosed |
| CN-115490854-A | Low-dielectric, high-heat-resistant and low-water-absorption high-performance polyimide, and preparation method and application thereof | 江西有泽新材料科技有限公司 | 2022-12-20 | — | — | CN | disclosed |
| CN-112979582-A | Preparation method of diamine containing phenothiazine structure and synthetic polyimide | 湖南工业大学 | 2021-06-18 | — | — | CN | disclosed |
| CN-106588890-B | Antiviral compounds | 吉利德制药有限责任公司 | 2020-11-27 | — | — | CN | disclosed |
| CN-111763182-A | Diamine containing phenothiazine and amide structures and polyimide thereof | 湖南工业大学 | 2020-10-13 | — | — | CN | disclosed |
| CN-111087364-A | Antibacterial diamine prepared from medical intermediate and preparation method thereof | 湖南工业大学 | 2020-05-01 | — | — | CN | disclosed |
| EP-3626716-A1 | ANTIVIRAL COMPOUNDS | Gilead Pharmasset LLC (US) | 2020-03-25 | — | — | EP | disclosed |
| US-9981955-B2 | Antiviral compounds | GILEAD PHARMASSET LLC (US) | 2018-05-29 | — | — | US | disclosed |
| US-8273341-B2 | Antiviral compounds | GILEAD SCIENCES, INC. (US) | 2012-09-25 | — | — | US | disclosed |
| US-20120157404-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2012-06-21 | — | — | US | disclosed |
| US-20120157404-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2012-06-21 | — | — | US | disclosed |
| US-8088368-B2 | Antiviral compounds | GILEAD SCIENCES, INC. (US) | 2012-01-03 | — | — | US | disclosed |
| US-8088368-B2 | Antiviral compounds | GILEAD SCIENCES, INC. (US) | 2012-01-03 | — | — | US | disclosed |
| US-8088368-B2 | Antiviral compounds | GILEAD SCIENCES, INC. (US) | 2012-01-03 | — | — | US | disclosed |
| US-20100310512-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. | 2010-12-09 | — | — | US | disclosed |
| US-20100310512-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. | 2010-12-09 | — | — | US | disclosed |
| US-20100310512-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. | 2010-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120157404-A1 | ANTIVIRAL COMPOUNDS | MAVS, EIF2AK2, ZC3HAV1 | SNCA 2309/4885NOX1 3704/4885GAA 151/4885 |
| US-20100310512-A1 | ANTIVIRAL COMPOUNDS | MAVS, EIF2AK2, ZC3HAV1 | SNCA 2309/4885NOX1 3704/4885GAA 151/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.